Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harmony Biosciences Holdings, Inc.

32.06
+0.13000.41%
Post-market: 32.060.00000.00%17:59 EDT
Volume:548.42K
Turnover:17.54M
Market Cap:1.84B
PE:12.23
High:32.46
Open:32.27
Low:31.66
Close:31.93
Loading ...

Zacks.com featured highlights include Harmony Biosciences, Ingevity, Gulfport Energy and Pitney Bowes

Zacks
·
24 Jan

4 High Earnings Yield Value Stocks to Buy as Trump Resumes Presidency

Zacks
·
23 Jan

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Zacks
·
20 Jan

U.S. Weekly Review: Stock Market Rises On Tame Inflation, Bank Earnings

Investor’s Business Daily
·
18 Jan

Harmony Biosciences Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Jan

Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge

Zacks
·
16 Jan

How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48%

Zacks
·
15 Jan

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Zacks
·
15 Jan

Are Investors Undervaluing Genmab (GMAB) Right Now?

Zacks
·
14 Jan

Harmony Biosciences price target raised to $32 from $31 at BofA

TIPRANKS
·
14 Jan

Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential

Insider Monkey
·
14 Jan

Harmony Biosciences Price Target Maintained With a $52.00/Share by Needham

Dow Jones
·
14 Jan

Harmony Biosciences Reports Preliminary Q4, 2024 Net Product Revenue; 2025 Revenue Guidance Issued

MT Newswires Live
·
13 Jan

Harmony Biosciences Projects Strong Revenue Growth for 2025

TIPRANKS
·
13 Jan

Harmony Biosciences : Outlook 2025 Net Revenue Between $820 to $860 Mln

THOMSON REUTERS
·
13 Jan

Press Release: Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts

Dow Jones
·
13 Jan

HC Wainwright Initiates Harmony Biosciences at Buy With $75 Price Target

MT Newswires Live
·
17 Dec 2024

Harmony Biosciences Set for Growth with WAKIX Expansion and Promising Neurology Pipeline, Says Analyst Patrick Trucchio

TIPRANKS
·
17 Dec 2024

Harmony Biosciences : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $75

THOMSON REUTERS
·
17 Dec 2024